Tuttle Capital Management’s Elevance Health ELV Stock Holding History

Tuttle Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,791	Closed	-$481K	–	210
2020 Q3	$481K	Buy	+1,791	New	+$482K	0.33%	72
2019 Q1	–	Sell	-2,700	Closed	-$1.55M	–	180
2018 Q4	$1.55M	Sell	2,700 -23,871	-90%	-$6.56M	0.59%	57
2018 Q3	$7.28M	Buy	26,571 +17,926	+207%	+$4.65M	1.38%	18
2018 Q2	$2.06M	Buy	8,645 +1,308	+18%	+$303K	1.39%	16
2018 Q1	$1.61M	Buy	7,337 +4,107	+127%	+$965K	1.3%	30
2017 Q4	$726K	Buy	+3,230	New	+$688K	0.88%	42
2017 Q3	–	Sell	-1,400	Closed	-$263K	–	72
2017 Q2	$263K	Buy	+1,400	New	+$252K	0.2%	69

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tuttle Capital Management's ELV Position: Q4 2020 in Review

Tuttle Capital Management sold out of Elevance Health (ELV) in Q4 2020, closing a stake of 1,791 shares — an estimated $481K sold.

Tuttle Capital Management first reported a position in ELV in Q2 2017 and held it in 7 quarters. The position peaked at $7.28M in Q3 2018. 1,170 funds tracked by Wall St. Rank hold ELV as of Q4 2020.

Tuttle Capital Management reported no remaining Elevance Health position as of Q4 2020 after selling out during the quarter.
Tuttle Capital Management sold 1,791 Elevance Health shares in Q4 2020, an estimated $481K.
Tuttle Capital Management first reported a position in Elevance Health in Q2 2017 and held it in 7 quarters.
Tuttle Capital Management's Elevance Health position peaked at $7.28M in Q3 2018.
1,170 funds tracked by Wall St. Rank held Elevance Health as of Q4 2020.

Based on Tuttle Capital Management's 13F filing for Q4 2020, filed 20 Jan 2021.